LAST PRICE - AT THE CLOSE
DRUG is UP 75% since the begininning of the year
DRUG is UP 10% ABOVE 20 day SMA
DRUG is UP 72% ABOVE 200 day SMA
PROFITABLE: NO
EPS: $-0.536582
EARNINGS MOMENTUM: YES
0.05% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 20.1% AWAY FROM ALL-TIME HIGHS OF $79.02 |
 |
DRUG IS UP 75% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 191% OVER THE PAST 12 MONTHS |
 |
DRUG IS UP 26% OVER THE PAST 1 MONTH |
 |
4% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 10/17 |
 | New premarket low. ... | 10/17 |
 | Up 4% for the day. | 10/17 |
 | Down 5% for the day. | 10/17 |
 | Crossed above VWAP | 10/17 |
 |
DRUG moved up 0 in the previous minute |
 |
DRUG is up 0.02 over the last hour |
 |
DRUG is up 4.9% over the last 5 days |
 |
DRUG is 3.3 above its 8 day SMA |
| $62.62 |   DAY |
$69.72 |
| $63.70 | PREVIOUS DAY |
$70.19 |
| $57.00 |  WEEK |
$70.23 |
| $48.90 | MONTH |
$70.23 |
| $21.10 | YEAR |
$79.02 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
